Summary
At the time being the only clinical relevance of the determination of apolipoproteins appears to be the use in monitoring the course of a disease of lipid metabolism. Apolipoproteins AI and B are very stable parameters which can be determined with high precision. If one could agree on one method for determination of apo B or establish a central laboratory, the determination of apo B in dried blood-spots for screening purposes is desirable. By this way not only cases of familial hypercholesterolemia could be detected very early in the infant, but also early enough in one of the parents. This is meaningful since we have adequate means of treating this disorder.
Lack of standardization and of agreement on methodology so far has hindered prospective data regarding the clinical significance of apolipoprotein measurement.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag/Wien
About this chapter
Cite this chapter
Wieland, H. (1991). The clinical relevance of apolipoprotein determination. In: Rosseneu, M., Widhalm, K., Jarausch, J. (eds) Apolipoproteins in Lipid Disorders. Springer, Vienna. https://doi.org/10.1007/978-3-7091-9148-4_6
Download citation
DOI: https://doi.org/10.1007/978-3-7091-9148-4_6
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-82273-9
Online ISBN: 978-3-7091-9148-4
eBook Packages: Springer Book Archive